Patent 7598251 was granted and assigned to Smithkline Beecham Limited on October, 2009 by the United States Patent and Trademark Office.
The present invention relates to aminopyrazine derivatives, compositions and medicaments containing the same, as well as processes for the preparation and use of such compounds, compositions and medicaments. Such aminopyrazine derivatives are useful in the treatment of diseases associated with inappropriate tyrosine and/or serine/threonine kinase activity.